Top section
Top section
UK follow-ons bring a secondary employee selldown and an increased primary capital raise
Helios's Moroccan health tech company T2S lists in Casablanca
Frédéric Despagne will also lead equity and derivatives sales across EMEA
More articles
More articles
More articles
-
Ever rising stock prices, despite the ravages of the Covid-19 pandemic and a looming global recession, have prompted fears that equity markets are becoming frothy or even a bubble. In such an environment, many investors begin to turn to safer assets and Vladislav Barshinov, CEO of Russia’s GV Gold, is hoping that investors will look to gold as his company considers the possibility of an IPO in 2021. -
Retail shareholders have been excluded from a string of recent hot IPOs on the London Stock Exchange. This does little to dispel accusations that financial markets are the preserve of the elite.
-
Hydrogen Refueling Solutions, a French company that designs and manufactures refuelling stations, has priced a popular IPO on the Euronext Paris exchange, the latest sign that hydrogen technology is gaining mainstream enthusiasm among green investors.
-
Autolus Therapeutics, the UK biopharmaceutical company focused on T cell therapies for cancer, is raising additional capital on the Nasdaq.
-
Chinese regulators have made a long overdue move to reduce the number of boards at the Shenzhen stock exchange. That points to a greater commitment towards streamlining the country’s sometimes confounding capital markets.
-
China-based Betta Pharmaceuticals, a developer of cancer treatments, is planning a Hong Kong IPO, having filed draft paperwork with the city’s stock exchange on Monday.
Sub-sections
shared comment list
